Forvard narx/daromad multiplikatori: Cumberland Pharma (CPIX)
Xomashyo yetishmasligi xavflari va logistik uzilishlar Cumberland Pharmaceuticals (CPIX) biznesiga bosim o'tkazmoqda. Kompaniyaning forward P/S ko'rsatkichi ushbu tebranishlarni aniq namoyish etadi, bunda 3.50 qiymati joriy metrikaga mos keladi. Kristalose va Caldolor mahsulotlarining shifoxona standartlariga integratsiyasi barqarorlikni ta'minlamoqda, qadoqlash liniyalarining rejalashtirilgan modernizatsiyasi davomida esa ishlab chiqarish quvvatlari uzluksiz ishlashda davom etmoqda.
CPIX (cumberlandpharma.com): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
- biznesning balans baholash tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Cumberland Pharmaceuticals|CPIX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Cumberland Pharmaceuticals Inc.|CPIX - Jamlangan qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Cumberland Pharmaceuticals Inc.|CPIX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzlari Cumberland Pharmaceuticals|Tezkor likvidlik cumberlandpharma.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
CPIX - Kompaniya foydasi|Prognoz qilingan kelajakdagi foyda Cumberland Pharmaceuticals|CPIX - Narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati Cumberland Pharmaceuticals|CPIX - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Cumberland Pharmaceuticals|CPIX - Foizlar, soliqlar, eskirish va amortizatsiya chegirilmasdan oldingi foyda|Bir aksiya uchun sof foyda (EPS TTM) Cumberland Pharmaceuticals|CPIX - Sirpanuvchi yil uchun bir aksiya uchun foyda|Choraklik EPS foyda o'sishi cumberlandpharma.com|CPIX - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Cumberland Pharmaceuticals
- sotuvlar va tushum bo'yicha ma'lumotlar:
Kompaniyaning jamlanma tahlili:CPIX (Cumberland Pharma)
Cumberland Pharmaceuticals (CPIX) kompaniyasining shifoxona mahsulotlaridan tushadigan barqaror pul oqimi bozor kapitalizatsiyasining kutilayotgan savdo hajmi nisbatiga asoslangan ob'ektiv biznes baholashini amalga oshirish imkonini beradi. Forward P/S metrikasini tahlil qilib, investor 3.50 joriy qiymatini ko'radi, bu esa aktivning uzoq muddatda daromad keltirish va majburiyatlarni bajarish qobiliyatiga nisbatan qanchalik past baholanganlik darajasini aniqlashga yordam beradi.
Cumberland Pharmaceuticals kimlar bilan raqobatlashadi
Forvard P/S multiplikatori HLN (Haleon PLC)|Forvard P/S multiplikatori Kenvue Corp KVUE|Verona Pharma PLC - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati jyongbio.com|LGND: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati AMRX|Narxning prognoz qilingan daromadga nisbati Perrigo Company|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alvotech ALVO|Forvard P/S multiplikatori LQDA|GLPG: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori ANIP (ANI Pharmaceuticals, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati MannKind Corp (MNKD)|AMPH: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati TBPH|AQST (Aquestive Corp) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori scPharmaceuticals Inc. (SCPH)|Forvard narx/daromad multiplikatori TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati SXT Pharmaceuticals SXTC|Sotuvga nisbatan forvard narx EPRX|BHST - Narxning prognoz qilingan daromadga nisbati|eXoZymes (EXOZ) - Forvard narx/daromad multiplikatori|ORMP: Forvard P/S multiplikatori|ENTX: Narxning kutilayotgan daromadga nisbati|HYFT (ipatherapeutics.com) - Forvard P/S multiplikatori|Forvard P/S multiplikatori ABVC BioPharma|Narxning prognoz qilingan daromadga nisbati Quantum BioPharma (QNTM)|FibroGen (FGEN) - Prognoz narxning daromadga nisbati|Forvard P/S multiplikatori TELO (telomirpharma.com)|RANI - Forvard narx/daromad multiplikatori|SNYR - Narxning prognoz qilingan daromadga nisbati|rallybio.com - Narxning kutilayotgan daromadga nisbati|LEXX: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Pulmatrix Inc|PTHL (Pheton Holdings) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Aptorum Group Limited APM|Narxning prognoz qilingan daromadga nisbati Lyra Therapeutics (LYRA)|Forvard narx/daromad multiplikatori Impact BioMedical Inc IBO|Narxning prognoz qilingan daromadga nisbati tnfpharma.com TNFA|Sotuvga nisbatan forvard narx YCBD|PainReform Ltd - Forvard P/S multiplikatori|Altamira Therapeutics Ltd (CYTO) - Forvard narx/daromad multiplikatori|lipella.com (LIPO) - Narxning prognoz qilingan daromadga nisbati|OptiNose (OPTN) - Forvard P/S multiplikatori|PIRS (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|PROC: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Petros Pharmaceuticals, Inc. (PTPI)|Forvard P/S multiplikatori Qilian International Corp (QLI)|ACELYRIN, Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori tffpharma.com TFFP
